We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$15.1B
AUM Growth
+$2.22B
Cap. Flow
+$548M
Cap. Flow %
3.64%
Top 10 Hldgs %
28.62%
Holding
2,384
New
671
Increased
477
Reduced
577
Closed
562

Sector Composition

Rank Sector Weight
1 Industrials 11.79%
2 Technology 9.94%
3 Financials 9.21%
4 Consumer Discretionary 9.02%
5 Healthcare 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTN icon
901
Vail Resorts
MTN
$5.3B
$1.5M 0.01%
+7,023
New +$1.54M
CX icon
902
Cemex
CX
$16.3B
$1.5M 0.01%
193,200
+94,700
+96% +$644K
RJF icon
903
Raymond James Financial
RJF
$34B
$1.49M 0.01%
13,335
+9,106
+215% +$937K
PACB icon
904
Pacific Biosciences
PACB
$370M
$1.48M 0.01%
151,376
-129,124
-46% -$1.06M
FUSN
905
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$1.48M 0.01%
+153,792
New +$747K
MRTX
906
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.47M 0.01%
+25,000
New +$1.41M
SUM
907
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$1.47M 0.01%
38,110
-21,804
-36% -$756K
GLNG icon
908
Golar LNG
GLNG
$5.13B
$1.46M 0.01%
63,700
-359,500
-85% -$8.06M
MRNA icon
909
Moderna
MRNA
$23.6B
$1.46M 0.01%
14,696
-3,323
-18% -$279K
STRO icon
910
Sutro Biopharma
STRO
$421M
$1.45M 0.01%
33,860
-1,640
-5% -$52K
FLNG icon
911
FLEX LNG
FLNG
$1.67B
$1.44M 0.01%
+49,700
New +$1.49M
BNTX icon
912
BioNTech
BNTX
$23.5B
$1.44M 0.01%
13,677
+11,377
+495% +$1.15M
CMCSA icon
913
Comcast
CMCSA
$90B
$1.44M 0.01%
32,908
-140,883
-81% -$6.04M
NFE icon
914
New Fortress Energy
NFE
$101M
$1.44M 0.01%
+38,200
New +$1.32M
APPF icon
915
AppFolio
APPF
$7.04B
$1.44M 0.01%
+8,318
New +$1.56M
SFNC icon
916
Simmons First National
SFNC
$3.39B
$1.44M 0.01%
72,490
-47,823
-40% -$800K
RYAN icon
917
Ryan Specialty Holdings
RYAN
$5.55B
$1.44M 0.01%
33,400
+10,665
+47% +$481K
CGEM icon
918
Cullinan Oncology
CGEM
$1.14B
$1.44M 0.01%
141,000
+19,200
+16% +$170K
SKYW icon
919
Skywest
SKYW
$4.34B
$1.43M 0.01%
+27,460
New +$1.23M
DTE icon
920
DTE Energy
DTE
$29.1B
$1.43M 0.01%
13,000
+4,800
+59% +$492K
BTI icon
921
British American Tobacco
BTI
$128B
$1.43M 0.01%
+48,900
New +$1.49M
DKS icon
922
Dick's Sporting Goods
DKS
$18.7B
$1.42M 0.01%
9,697
+4,370
+82% +$531K
FLNC icon
923
Fluence Energy
FLNC
$2.44B
$1.42M 0.01%
59,600
+17,400
+41% +$366K
GFF icon
924
Griffon
GFF
$4.86B
$1.41M 0.01%
23,143
-4,039
-15% -$187K
DHC
925
PUT
Diversified Healthcare Trust
DHC
$2.14B
$1.41M 0.01%
376,900
+294,900
+360% +$693K

Similar funds

Schonfeld Strategic Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Schonfeld Strategic Advisors held 2,384 positions worth $15.1B, up 17% from $12.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Schonfeld Strategic Advisors deployed $548M of net new capital in Q4 2023, opening 671 new positions and adding to 477 existing holdings. Its largest new stake was Equifax: 214,316 shares worth $53M.

By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Union Pacific, an estimated $115M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2023 buy was Equifax: 214,316 shares worth $53M.
  • Schonfeld Strategic Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.67B increase.
  • Schonfeld Strategic Advisors's biggest Q4 2023 reduction was Union Pacific, cutting an estimated $115M.
  • Schonfeld Strategic Advisors fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2023, selling an estimated $94.5M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 29% of its $15.1B portfolio in Q4 2023.
  • Schonfeld Strategic Advisors opened 671 new positions and closed 562 in Q4 2023.
  • Schonfeld Strategic Advisors's portfolio value rose 17% quarter-over-quarter to $15.1B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.